Literature DB >> 17872473

Leptin signaling and obesity: cardiovascular consequences.

Ronghua Yang1, Lili A Barouch.   

Abstract

Leptin, among the best known hormone markers for obesity, exerts pleiotropic actions on multiple organ systems. In this review, we summarize major leptin signaling pathways, namely Janus-activated kinase/signal transducers and activators of transcription and mitogen-activated protein kinase, including possible mechanisms of leptin resistance in obesity. The effects of leptin on the cardiovascular system are discussed in detail, including its contributions to hypertension, atherosclerosis, depressed myocardial contractile function, fatty acid metabolism, hypertrophic remodeling, and reduction of ischemic/reperfusion injury. The overall goal is to summarize current understanding of how altered leptin signaling in obesity contributes to obesity-related cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17872473     DOI: 10.1161/CIRCRESAHA.107.156596

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  115 in total

1.  Diabetic Cardiomyopathy: Mechanisms and Therapeutic Targets.

Authors:  Pavan K Battiprolu; Thomas G Gillette; Zhao V Wang; Sergio Lavandero; Joseph A Hill
Journal:  Drug Discov Today Dis Mech       Date:  2010

2.  Regulation of Blood Pressure, Appetite, and Glucose by Leptin After Inactivation of Insulin Receptor Substrate 2 Signaling in the Entire Brain or in Proopiomelanocortin Neurons.

Authors:  Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Nathan J Freeman; Ammar J Alsheik; Ahmad Adi; John E Hall
Journal:  Hypertension       Date:  2015-11-30       Impact factor: 10.190

3.  iBAT sympathetic innervation is not required for body weight loss induced by central leptin delivery.

Authors:  Isabelle Côté; Yasemin Sakarya; Sara M Green; Drake Morgan; Christy S Carter; Nihal Tümer; Philip J Scarpace
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-10-31       Impact factor: 4.310

4.  Uncovering the molecular mechanisms behind disease-associated leptin variants.

Authors:  Ellinor Haglund; Lannie Nguyen; Nicholas Peter Schafer; Heiko Lammert; Patricia Ann Jennings; José Nelson Onuchic
Journal:  J Biol Chem       Date:  2018-06-27       Impact factor: 5.157

5.  Divergent phenotype of rat thoracic and abdominal perivascular adipose tissues.

Authors:  Jaume Padilla; Nathan T Jenkins; Victoria J Vieira-Potter; M Harold Laughlin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-06       Impact factor: 3.619

6.  Adipose tissue and vascular phenotypic modulation by voluntary physical activity and dietary restriction in obese insulin-resistant OLETF rats.

Authors:  Jacqueline M Crissey; Nathan T Jenkins; Kasey A Lansford; Pamela K Thorne; David S Bayless; Victoria J Vieira-Potter; R Scott Rector; John P Thyfault; M Harold Laughlin; Jaume Padilla
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-02-12       Impact factor: 3.619

7.  Chronic hyperleptinemia results in the development of hypertension in pregnant rats.

Authors:  Ana C Palei; Frank T Spradley; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-03-11       Impact factor: 3.619

8.  Prolonged leptin treatment increases transient outward K⁺ current via upregulation of Kv4.2 and Kv4.3 channel subunits in adult rat ventricular myocytes.

Authors:  Nieves Gómez-Hurtado; María Fernández-Velasco; María Soledad Fernández-Alfonso; Lisardo Boscá; Carmen Delgado
Journal:  Pflugers Arch       Date:  2013-09-18       Impact factor: 3.657

9.  Rescue of cardiac leptin receptors in db/db mice prevents myocardial triglyceride accumulation.

Authors:  Michael E Hall; Matthew W Maready; John E Hall; David E Stec
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-06-17       Impact factor: 4.310

10.  Role of proopiomelanocortin neuron Stat3 in regulating arterial pressure and mediating the chronic effects of leptin.

Authors:  John H Dubinion; Jussara M do Carmo; Ahmad Adi; Shereen Hamza; Alexandre A da Silva; John E Hall
Journal:  Hypertension       Date:  2013-03-25       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.